Avid Bioservices Inc (CDMO)

[Fire Fox]

Your question reminds me of SK's recent emphasis on the fact that there has been a very high level of consistency between pre-clinical / early clinical data, and the current results. For most biotech companies, there is no such consistency and the results of each trial are a crap shoot.

With the confidence the Company now has in the predictive value of their early data, I bet they wait for the unblinding before inking a Bavi deal.